SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

Поділитися
Вставка
  • Опубліковано 6 жов 2024
  • Organised by EuReCa-M Working Group
    Speaker
    Lucia Del Vecchio, Italy
    Panellists
    Olga Balafa, Greece
    José Manuel Valdivielso, Spain
    Moderator
    Beatriz Fernandez-Fernandez, Spain

КОМЕНТАРІ •